The Immunopeptidomics Ontology (ImPO)

Area of Science:

• Immunology and Bioinformatics
• Computational Biology and Systems Biology

Background:

• Adaptive immunity relies on Major Histocompatibility Complex Class I (MHC-I) presenting peptides for cell recognition.
• Immunopeptidomics studies the diverse peptides presented by cells, crucial for understanding cancer immunotherapies.
• The emerging field of immunopeptidomics lacks standardized terminology and semantics, hindering data integration and clinical application.

Purpose of the Study:

• To develop the first standardized terminology and semantic framework for the immunopeptidomics domain.
• To create the ImmunoPeptidomics Ontology (ImPO) to encapsulate and systematize immunopeptidomics data.
• To bridge the gap between proteomics and genomics communities in cancer research.

Main Methods:

• Development of the ImmunoPeptidomics Ontology (ImPO) using expert knowledge.
• Systematization of data from immunopeptidomics experiments and bioinformatics analyses.
• Integration of ImPO with 24 existing ontologies, including NCI Thesaurus and Mondo Disease Ontology.

Main Results:

• ImPO provides a standardized vocabulary and semantic structure for immunopeptidomics data.
• The ontology facilitates data integration, querying, inference, and knowledge generation.
• ImPO establishes cross-references to relevant biomedical ontologies, enhancing data interoperability.

Conclusions:

• ImPO is the first ontology to standardize immunopeptidomics terminology and semantics.
• This standardization is essential for managing complex and heterogeneous immunopeptidomics data.
• ImPO supports data integration and knowledge discovery, crucial for advancing cancer immunogenomics and clinical applications.